Literature DB >> 15727236

Cerebrospinal fluid findings in Devic's neuromyelitis optica.

M Zaffaroni1.   

Abstract

Relapsing Devic's neuromyelitis optica (DNO) may be clinically undistinguishable from multiple sclerosis (MS), thus the differential diagnosis relies mainly on neuroimaging and cerebrospinal fluid (CSF) findings. We studied CSF samples from 44 patients with DNO submitted to at least one lumbar puncture. Pleocytosis, IgG synthesis and blood brain barrier damage were the most frequent abnormalities, pleocytosis being very suggestive of DNO in patients fulfilling clinical and MRI diagnostic criteria. Pleocytosis > or =50 cells/mm3 is more frequent in the active phases of the disease. Oligoclonal bands (OBs) should be re-considered within the diagnostic criteria of DNO for possible variations in time: at variance with MS they may also disappear. Thus, more than one CSF examination should be done in the presence of suspected DNO, preferably in different disease phases. Although uncommon, OBs do not exclude DNO if optic nerve and spinal cord are the only sites of white matter damage, provided that cerebral MRI is normal at onset and during follow up.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15727236     DOI: 10.1007/s10072-004-0343-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  10 in total

1.  Proteome analysis of haptoglobin in cerebrospinal fluid of neuromyelitis optica.

Authors:  Shumei Bai; Shilian Liu; Xuxiao Guo; Zhaoyu Qin; Banqin Wang; Xiaohong Li; Yanjiang Qin
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

2.  A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12 years: MRI follow up and histological findings.

Authors:  H Köller; E Neuen-Jacob; A Saleh; B C Kieseier; S Jander; H-P Hartung
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

Review 3.  [Neuromyelitis optica].

Authors:  S Jarius; B Wildemann
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

4.  Long-term outcome of acute and subacute myelopathies.

Authors:  S Debette; J de Sèze; J-P Pruvo; H Zephir; F Pasquier; D Leys; P Vermersch
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

5.  Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.

Authors:  Sven Jarius; Diego Franciotta; Friedemann Paul; Klemens Ruprecht; Roberto Bergamaschi; Paulus S Rommer; Reinhard Reuss; Christian Probst; Wolfgang Kristoferitsch; Klaus Peter Wandinger; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-09-08       Impact factor: 8.322

6.  New insights into neuromyelitis optica.

Authors:  Woojun Kim; Su-Hyun Kim; Ho Jin Kim
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

7.  Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.

Authors:  Yong Guo; Stephen D Weigand; Bogdan F Popescu; Vanda A Lennon; Joseph E Parisi; Sean J Pittock; Natalie E Parks; Stacey L Clardy; Charles L Howe; Claudia F Lucchinetti
Journal:  Acta Neuropathol       Date:  2017-02-09       Impact factor: 17.088

8.  Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.

Authors:  Derya Kaya; Egemen Idiman; Serkan Ozakbaş
Journal:  Autoimmune Dis       Date:  2012-12-30

9.  Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis.

Authors:  Dragan Lepur; Vjerislav Peterković; Nevija Kalabrić-Lepur
Journal:  Neurol Sci       Date:  2009-01-15       Impact factor: 3.830

10.  Association between neuromyelitis optica and tuberculosis in a Chinese population.

Authors:  Rui Li; Xiaonan Zhong; Wei Qiu; Aimin Wu; Yongqiang Dai; Zhengqi Lu; Xueqiang Hu
Journal:  BMC Neurol       Date:  2014-02-20       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.